Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year net income at Sanofi SA changed little (from 5.40bn to 5.56bn) despite revenues that grew 6.41%.
Gross margin70.94%
Net profit margin13.59%
Operating margin18.38%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in EURView more

In 2024, cash reserves at Sanofi SA fell by 1.27bn. However, the company earned 8.91bn from its operations for a Cash Flow Margin of 20.13%. In addition the company used 4.41bn on investing activities and also paid 5.76bn in financing cash flows.
Cash flow per share3.65
Price/Cash flow per share13.08
Book value per share34.53
Tangible book value per share4.79
More ▼

Balance sheet in EURView more

Sanofi SA has a Debt to Total Capital ratio of 22.05%.
Current ratio1.37
Quick ratio0.688
Total debt/total equity0.2841
Total debt/total capital0.2205
More ▼

Growth rates in EUR

SmartText is unavailable
EPS growth(5 years)14.01
EPS (TTM) vs
TTM 1 year ago
54.42
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.